Correction to: The impact of metformin use on the outcomes of relapse‑remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open‑label randomized controlled trial
Crossref DOI link: https://doi.org/10.1007/s00415-024-12249-9
Published Online: 2024-03-18
Published Print: 2024-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abdelgaied, Mohamed Y.
Rashad, Mohamed Hamed
El‑Tayebi, Hend M.
Solayman, Mohamed H. http://orcid.org/0009-0008-3723-1052
Text and Data Mining valid from 2024-03-18
Version of Record valid from 2024-03-18
Article History
First Online: 18 March 2024
Free to read: This content has been made available to all.